Is there a #hepsky feed? Thanks to all who contributed to the @AASLD2024 #TLM2024 #liversky it was a perfect online experience 🥰 Excellent presentations Learned new treatment options for #MetALD #foodaddiction
And with that, #tlm2024 is in the books!
Happy to share our findings about naltrexone in decompensated cirrhosis, at #TLM2024.
Grateful for the support of my mentors Dr Devuni, @juanpabloarab.bsky.social, and my excellent co-author Dr Cooper! #LiverSky
Always nice to see the team work being showcased in the wrap up session of AASLD #TLM2024. Well deserved Dr Leung.
Our own Dr. Hannah Carr presenting on the role of palliative care for patients getting balloon tamponade for acute variceal bleeding at #tlm2024 @cameronhenneberg.bsky.social
Packed house at Women’s luncheon for inspiring talk by past #AASLD president Dr. Teresa Wright, great way to close out my time at #TLM2024 💪💪🤸♀️
Patient facing AI is here, it has may potential benefits , but also has many potential challenges. Excellent talk by # Aly Strauss #TLM2024
#HappeningNow Excellent session for anyone interested in large language models/ Gen AI in field of medicine. Exciting future for integration of LLMs in EHR and so much more.
#TLM2024 #AASLD
Looking to re-engage with some non-toxic social media - I’ll start with a great trip to #aasld #tlm2024 with my little hepatologist
Come check out our productive bunch!
3 for 3 😊
Learn about how @DCVAMC is improving health care delivery in MASLD care, transplant and management of patients with cACLD.
Don’t miss these posters
3173
3338
3272
#livertwitter #TLM24 #TLM2024
Green background with yellow letters describing the program director’s workshop
A list of presenters and moderators for the session with many of their corresponding pictures.
It’s back!! Come check out the Program Director’s Workshop today at 3:45 PM in meeting room 1, most slides will be available after the session #TLM2024 Liver fellows welcome!
Hey #liversky #TLM2024 #TLM24
Do not forget about our controversies in portal HTN session.
Come with your 🔥 questions or respond to this 🧵. I try my best to cover them with my co-moderator @NorthupHepTXP and our experts @VirginiaHdezGea @JuanAbraldes @JonathanStineMD
#TLM2024 #TARGETNASH
impact of GLP-1 on clinical outcomes in #cirrhosis
non-GLP-users:
⬆️ decomp HR 1.69
⬆️ mortality HR 2.28
💪 large, real world, clinical
➡️ lingering questions:
- role of muscle mass changes & outcomes in GLP users?
- is lack of GLP a marker for lack of access?
#liversky
#HappeningNow #TLM Highly informative session on global perspectives of HCC with insights from epidemiology to therapeutics with an expert panel
#TLM2024 #AASLD
As a caregiver, I'm grateful that #TLM2024 includes the voice of the patient/caregiver. Looking forward to great patient sessions and connecting with liver friends.
AASLD #TLM2024 meeting! Excellent sessions and grateful to be recognized as an Emerging Liver Scholar! #ELS
Great pHTN session at #TLM2024 ➡️ statin, AC, & anti-fibrotics are promising
➡️ carvedilol for all
➡️ preemptive #TIPS is life-saving with NNT 4️⃣‼️
#TLM2024 #liversky #portalhypertension
@atoosarabiee.bsky.social
Hepatologists rock! 🎸
#TLM2024
#AALSD2024
Great first day at The Liver Meeting! A huge thanks to the @AASLDFoundation Emerging Liver Scholars program and to Dr. Vanatta and my mentors in all things liver surgery at UTHSC and St. Jude! 📈
#TLM2024 #LiverSky #SurgSky
Come learn about our findings about trends of #LT for #HCC in the US over the last decade! That’s a poster of distinction as well ⭐️🤩
#TLM2024
#AASLD
What is the risk of progression to liver disease with high risk alcohol use?
Ponni Perumalswami shares natural history and modifiable risk factors at #TLM2024
Proposed algorithm for selecting patients with MASH for treatment with resmetirom at #TLM2024 #LiverSky
Day 3 of engaging more on @bsky.app. Today I am heading to San Diego for #TLM2024. I am looking forward to seeing my #SurgSky and #HPBSky friends and learning more about my favorite organ, the liver :)
#TLM2024 few moments away
Amazing weather and view
Blue sky at San Diego
One AASLD #TLM2024 session that I'm eagerly awaiting is the debate on hepatologists prescribing systemic therapy for HCC
With neoadjuvant, adjuvant and combination therapies potentially on the horizon, there's a compelling supply/demand argument but lots of barriers
Should be interesting...
Hello #LiverSky what a great time to start with #TLM2024 getting ready to start! I’m looking forward to connecting with like-minded professionals who share my passion for
hepatology #TLM24. #hepatology #AASLD